Navigation Links
Leading German Researcher Awarded Elsevier's 2011 Tetrahedron Prize
Date:2/28/2012

AMSTERDAM, February 28, 2012 /PRNewswire/ --

Professor Dr. Manfred T. Reetz honored for his work on synthetic organic chemistry

Elsevier, a world-leading provider of scientific, technical and medical information products and services, announces that leading German scientist, Professor Dr. Manfred T. Reetz (Emeritus) of the Max-Planck-Institut fur Kohlenforschung and Hans Meerwein Research Professor at Philipps-Universität, Marburg, has been awarded the 2011 Tetrahedron Prize for Creativity in Organic Chemistry.

The Executive Board of Editors of Elsevier's Tetrahedron Publications selected Professor Reetz for his many outstanding contributions to synthetic organic chemistry, especially for his work on enantioselective catalysis to control stereoselectivity. He has been prominent in the discovery and development of enzyme catalysts for asymmetric reactions. These enzyme catalysts can be developed in the laboratory to suit a specific reaction using a process of directed evolution: repeatedly selecting and growing the host organism which shows the highest yield of the enzyme required.

"Winners of the Tetrahedron prize are leaders in their field. They are the scientists who, through their outstanding creativity in organic chemistry, have moved the field in a new and significant direction. Elsevier is proud to recognize this creativity by the presentation of this prize," Diddel Francissen, Executive Publisher for the Tetrahedron Publications at Elsevier, said of the annual prize.

Elsevier's Tetrahedron Prize consists of a gold medal and a monetary award. Established in 1980 to honor the memory of the founding co-Chairmen of the Tetrahedron Publications, Professor Sir Robert Robinson and Professor Robert Burns Woodward, it is awarded for creativity in Organic Chemi
'/>"/>

SOURCE Elsevier
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Johns Hopkins Health System is 100th healthcare Provider to Integrate OnBase With Leading Electronic Medical Record System
2. Leading Pharmaceutical Marketing Research and Consulting Company Introduces Intelligent Efficiency Program
3. iBioSeminars and iBioMagazine: Free, Online Biology Seminars and Short Talks by Leading Scientists
4. Northwest Bio Reaffirms Its Freedom to Operate; Refutes Other Parties Misleading Patent Assertions
5. BioSpace Spotlights Leading Life Science Community
6. Leading Investigator to Present Clinical Data on Generex Oral-lyn™ at International Diabetes Federation Meetings in Dubai
7. CenTrak, a Leading Real-Time Location System Provider, Unveils New Branding
8. Oral Therapy Teriflunomide (Aubagio™(*)) Significantly Reduces Relapses Leading to Hospitalization of Patients with Multiple Sclerosis
9. CTRI Confirms Leading Indian CRO Supports Majority of Hemophilia Trials in India
10. Californias Industrial Biotechnology Workforce: Creating Jobs and Leading Innovation
11. OncoGenex Announces Publication of Custirsen Phase II Clinical and Pre-Clinical Data in Leading Cancer Journals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... (PRWEB) February 26, 2015 On behalf ... its affiliated companies, Wilentz, Goldman & Spitzer, P.A. ... trade secrets lawsuit against Genewiz Inc. in excess of ... and utilized GenScript’s trade secrets, and that it improperly ... court entered an order denying motions for judgment notwithstanding ...
(Date:2/26/2015)... , Feb. 26, 2015 The healthcare landscape ... ever-changing arena, Frost & Sullivan will host its 20 ... Executive MindXchange , March 8 to 10, at the Hilton ... Calif. This event is a platform ... leaders to discuss industry disruptions and how to succeed in ...
(Date:2/26/2015)... February 26, 2015 The Pittcon ... at the Ernest N. Morial Convention Center in ... as of February 19, 2015) displaying products and ... academic, and government labs. The Exposition will offer ... not limited to, analytical chemistry; drug discovery; nanotechnology; ...
(Date:2/26/2015)... Innovation is more urgent than ever. ... of the world and transforming global markets in ... to health care, disruption is constantly underway. , ... trends shake the foundations of established business models, ... to survive the next wave of mega-change. , ...
Breaking Biology Technology:Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 2Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 3Embrace the Future of Medical Technologies with Frost & Sullivan 2Embrace the Future of Medical Technologies with Frost & Sullivan 3Pittcon 2015 Announces Exposition Highlights 2One Million Acts of Innovation Canada Creates Partnership with The Economist Events’ Innovation Forum 2
... Dedicating this year,s,Venture Forum to the life sciences industry, ... in developing and producing the 2008,Life Sciences Venture Forum, ... early-stage life sciences companies from the U.S. and,around the ... place on,May 30, 2008, at the Santa Clara Convention ...
... Neurosciences,Inc. (OTC Bulletin Board: ILNS), announced today that ... the grant requirements to obtain a,European patent relating ... by the Company for the treatment of Alzheimer,s,disease. ... several weeks. Other,patents related to the ANTISENILIN(R) antibodies ...
... 10 /PRNewswire-FirstCall/ - Oncothyreon Inc.,(Nasdaq: ONTY ) ... PX-478, pharmacodynamic studies of PX-12 and preclinical studies ... of the American Association,for Cancer Research (AACR) in ... currently conducting a Phase 1 clinical trial of ...
Cached Biology Technology:Larta Institute Partners With Burrill & Company to Present the 14th Annual Life Sciences Venture Forum 2Larta Institute Partners With Burrill & Company to Present the 14th Annual Life Sciences Venture Forum 3Intellect Neurosciences, Inc. Receives Notice of Allowance and Completes Grant Requirements for Pivotal European Patent Related to Passive Immunization of Alzheimer's Disease 2Intellect Neurosciences, Inc. Receives Notice of Allowance and Completes Grant Requirements for Pivotal European Patent Related to Passive Immunization of Alzheimer's Disease 3Intellect Neurosciences, Inc. Receives Notice of Allowance and Completes Grant Requirements for Pivotal European Patent Related to Passive Immunization of Alzheimer's Disease 4Oncothyreon announces data from multiple small molecule programs to be presented at American Association of Cancer Research Annual Meeting 2Oncothyreon announces data from multiple small molecule programs to be presented at American Association of Cancer Research Annual Meeting 3
(Date:2/9/2015)... RICHARDSON, Texas , Feb. 9, 2015  Lintec ... novel fabrication methods for carbon nanotube (CNT) macrostructures, including ... Texas at Dallas (UTD). Leveraging the vast ... Tokyo, Japan , Lintec of America ... Richardson, TX , focusing on scaling ...
(Date:2/5/2015)... Calif. , Jan. 27, 2015 /PRNewswire/ ... provider of globally deployed, innovative test solutions ... announced the delivery of its TS-323 ... Space Systems Company (LMSSC). GENASYS is a ... demands of mission-critical applications that require performance ...
(Date:2/5/2015)... VIEW, Calif. , Feb. 3, 2015 /PRNewswire/ ... printer technology, demand from industries such as consumer ... global market for surface mount technology (SMT) screen ... equipment to automatic control will push the adoption ... dispensers will remain steady as glue dispensers are ...
Breaking Biology News(10 mins):Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 3Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 4Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 2Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 3Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 4End-user Demand Spurs Global SMT Screen Printers and Glue Dispensers Market 2End-user Demand Spurs Global SMT Screen Printers and Glue Dispensers Market 3
... step in the ongoing battle against secondhand tobacco smoke. They ... immediately detect the presence of secondhand smoke and even third-hand ... about the size of a matchbox car, the device uses ... A sensor chip then records the data on an SD ...
... University] A key advance, newly reported by chemists ... cheaper and more sustainable way to make acrylate, an ... fabrics to diapers. Chemical companies churn out billions ... propylene, a compound derived from crude oil. "What we,re ...
... after the FDA approved Kalydeco (Vx-770), the first drug of ... University of Missouri researchers believe they have found exactly how ... the future. Described in the current issue of the ... have redefined a key regulatory process in the defective protein ...
Cached Biology News:Scientists create new tools for battling secondhand smoke 2Scientists create new tools for battling secondhand smoke 3Breakthrough could lead to cheaper, more sustainable chemical production 2Discovery could increase efficacy of promising cystic fibrosis drug 2Discovery could increase efficacy of promising cystic fibrosis drug 3Discovery could increase efficacy of promising cystic fibrosis drug 4
Metamine is an autonomous data mining tool that extends the capabilities of conventional research teams. It is a proactive agent that searches for significant results buried within the GeNet data rep...
... Oxidative stress is the condition in which ... oxidant stimuli and the various antioxidants. Oxidative ... the pathogenesis of several diseases, including artherosclerosis, ... body possesses several antioxidant systems that are ...
... PolarScreen Progesterone Receptor (PR) Competitor Assay ... screening novel progesterone receptor binding compounds ... assay utilizes a fusion of glutathione ... of human progesterone receptor [PR-LBD(GST)] and ...
Compound(s) tested through a broad panel of 38 ligand binding and enzyme assays targeting the Central Nervous System. Used to determine selectivity and potential CV/Renal liabilities of compounds....
Biology Products: